scholarly journals Defining the mechanism of PDI interaction with disulfide-free amyloidogenic proteins: Implications for exogenous protein expression and neurodegenerative disease

2021 ◽  
Vol 174 ◽  
pp. 175-184
Author(s):  
Pingyu Yan ◽  
Zhiyuan Zou ◽  
Shiyao Zhang ◽  
Rui Wang ◽  
Tingting Niu ◽  
...  
2012 ◽  
Vol 12 (5) ◽  
pp. 347-361 ◽  
Author(s):  
Andreas N. Kuhn ◽  
Tim Beißert ◽  
Petra Simon ◽  
Britta Vallazza ◽  
Janina Buck ◽  
...  

2017 ◽  
Vol 2 ◽  
pp. 40
Author(s):  
Meliti Skouteri ◽  
Helfrid Hochegger ◽  
Antony M. Carr

The use of constitutive promoters to drive exogenous protein expression is an important tool for the study of diverse biological processes. To create and characterise a stably integrated expression system for DT40 cells, we constructed integration cassettes for three commonly used promoter elements; CMV, CBA or CAG, and used these to stably integrate a TOPBP1 transgene at the OVA locus, a transcriptionally silent locus commonly used in DT40. We next performed a comparative analysis of protein expression levels and identified CAG as the most efficient of the promoter elements we have tested in DT40 cells. To assess whether the site of integration affected the levels of transgene expression, a second chromosomal locus, immediately adjacent to the endogenous TOPBP1 gene, was tested for CAG. No major differences in TopBP1 overexpression were observed. This confirms that use of the OVA locus for integrating transgenes is a rational choice for DT40. Finally, we demonstrate that our stably integrated overexpression system (SIOS) constructs can be efficiently excised by the induction of tamoxifen-regulated Cre expression. Taken together, SIOS is an easy-to-use and versatile system for constitutive, reversible exogenous protein production that provides a range of potential expression levels. This will be a useful experimental tool for future DT40 experiments.


Vaccines ◽  
2021 ◽  
Vol 9 (2) ◽  
pp. 148
Author(s):  
Clayton J. Wollner ◽  
Justin M. Richner

Numerous vaccines have now been developed using the mRNA platform. In this approach, mRNA coding for a viral antigen is in vitro synthesized and injected into the host leading to exogenous protein expression and robust immune responses. Vaccines can be rapidly developed utilizing the mRNA platform in the face of emerging pandemics. Additionally, the mRNA coding region can be easily manipulated to test novel hypotheses in order to combat viral infections which have remained refractory to traditional vaccine approaches. Flaviviruses are a diverse family of viruses that cause widespread disease and have pandemic potential. In this review, we discuss the mRNA vaccines which have been developed against diverse flaviviruses.


2017 ◽  
Vol 2 ◽  
pp. 40
Author(s):  
Meliti Skouteri ◽  
Helfrid Hochegger ◽  
Antony M. Carr

The use of constitutive promoters to drive exogenous protein expression is an important tool for the study of diverse biological processes. To create and characterise a stably integrated expression system for DT40 cells, we constructed integration cassettes for three commonly used promoter elements; CMV (cytomegalovirus), CBA (chicken beta actin) or CAG (a hybrid promoter containing the CMV enhancer and chicken beta actin promoter), and used these to stably integrate a TOPBP1 transgene at the OVA locus, a transcriptionally silent locus commonly used in DT40. We next performed a comparative analysis of protein expression levels and identified CAG as the most efficient of the promoter elements we have tested in DT40 cells. To assess whether the site of integration affected the levels of transgene expression, a second chromosomal locus, immediately adjacent to the endogenous TOPBP1 gene, was tested for CAG. No major differences in TopBP1 overexpression were observed. This confirms that use of the OVA locus for integrating transgenes is a rational choice for DT40. Finally, we demonstrate that our stably integrated overexpression system (SIOS) constructs can be efficiently excised by the induction of tamoxifen-regulated Cre expression. Taken together, SIOS is an easy-to-use and versatile system for constitutive, reversible exogenous protein production that provides a range of potential expression levels. This will be a useful tool for future DT40 experiments.


Author(s):  
Elena Bossi ◽  
Maria Serena Fabbrini ◽  
Aldo Ceriotti

ALGAE ◽  
2018 ◽  
Vol 33 (4) ◽  
pp. 351-358 ◽  
Author(s):  
Tomasz Krupnik ◽  
Wioleta Wasilewska ◽  
Anna Drożak ◽  
Elżbieta Romanowska ◽  
Maksymilian Zienkiewicz

Sign in / Sign up

Export Citation Format

Share Document